☰
Healthcare companies are racing against time to develop a vaccine for COVID-19 which has killed thousands of people across the world. Given the dire situation, healthcare companies are seeking financial support from governments and philanthropists for developing novel COVID-19 treatments and vaccines.
A similar incident comes into light when AbCellera Biologics Inc., the Canada-based biotechnology firm, has received a financial commitment of up to USD 175.6 from the Canadian Government for accelerating efforts to develop novel therapies to treat COVID-19. The company is also expected to use this funding to develop cutting-edge technologies and manufacturing facilities for antibody treatment against future pandemic threats.
Sources cite that the company is using its antibody discovery platform to study blood samples of patients who have recovered from coronavirus disease. In collaboration with VRC (Vaccine Research Centre) at the National Institute of Allergy and Infection Diseases, the company has identified more than 500 unique human anti-SARS-CoV-2 antibodies. These antibodies may also be used to develop novel diagnostic tests to aid the medical community in monitoring COVID-19 spread.
Speaking on which, Navdeep Bains, Minister of Innovation, Science and Industry said that the Government of Canada is mobilizing its resources to confront COVID-19 and aiding the businesses and researchers that are working diligently to create novel therapies to tackle this pandemic. The funding would support AbCellera Biologicsto rapidly discover new solutions for COVID-19 while ensuring the nation’s long-term preparedness for future healthcare threats, Bains added.
Carl Hansen, Ph.D., CEO at AbCellera stated that the company is proud to have the support from the Canadian Government to rapidly find solutions to the ongoing pandemic.
As per sources, the company has received a financial commitment for funding under ISED’s (Innovation, Science and Economic Development) Strategic Innovation fund. With this initiative, the Government of Canada is aiming to support companies that are working on developing COVID-19 vaccines and critical medical supplies.
Source Credit - https://www.abcellera.com/news/2020-05-03
Fitbit, a Google company, is reportedly facing a series of privacy complaints within the European Union. These complaints revolve around allegations that the company is engaging in unlawful exporting of user data, thereby violating the EU's strin...
Social network X, previously known as Twitter, has reportedly unveiled more modifications that involve the retirement of certain legacy API endpoints. The company implemented adjustments to its API pricing in March, resulting in elevated costs for...
Zapata AI, a software enterprise dedicated to addressing intricate computational challenges, has reportedly unveiled a strategic partnership with IonQ, a leading figure in quantum computing hardware and commercial quantum application advancement. The...
The tech giant Meta has reportedly introduced AudioCraft, a framework capable of generating high-quality audio and music based on short text prompts. The AudioCraft framework aims to simplify the use of generative models for audio by providing a c...
GlaxoSmithKline Pharmaceuticals, the Indian arm of GSK plc based in the UK, reportedly recorded an 11% increase in its first-quarter profit, driven by robust demand for its vaccines. According to the company's statement, the consolidated profi...
© 2023 aeresearch.net. All Rights Reserved.
